chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 08-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps). At the time of the report, ABDOMINAL PAIN UPPER (Stomach cramps) had not resolved.            No treatment information provided.   This case was linked to MOD-2021-343023 (Patient Link).
Woke up with migraine.  Migraine gone by late AM on 11/16/2010.  Took a total of 3 prescribed migraine pills from onset until next morning to get rid of migraine.  This is the 1st time patient has had a migraine occur as a result of receiving the flu vaccine.  Has received the seasonal flu vaccine every year since 2002 resulting in just a sore arm afterwards.
Woke up on December 4 with palpitations, many, one right after another. Short of breath
Pain that began on the day of the vaccination and subsequently turned into paresthesias in the same arm in an ulnar distribution.
Body aches and fatigue for first 48 hrs, then acute onset nausea and profuse vomiting that lasted for 72 hrs, requiring 2 separate ER visits for IV fluids and aggressive anti-nausea therapy.
Was experiencing cold sores; Her hearing had gone to 50% level in both ears.; The reporter stated that the patient developed an injection site rash.; This spontaneous report was received from  the patient's husband referring to a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.     In 2013, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) VIAL 19400 PFU (strength, route, dose, frequency, anatomical location, lot # and expiration date were unknown) for prophylaxis, reconstituted with sterile diluyent.        On an unknown date, the patient experienced an injection site rash, cold sores(oral herpes), and her hearing had gone to 50% level in both ears (hypoacusis), and due to this event she visited the audiologist, and the patient received treatment due to the events.  At the time of the report, the outcome of oral herpes, injection site rash and hypoacusis was reported as not resolved. The reporter did not mention the causality assessement between the events and zoster vaccine live(ZOSTAVAX) vaccination.
I went to pharmacy on September the 6th 2023 for the Pneumonia 20 vaccine during the administration of the vaccine I experienced severe pain that continued for days, where I had to take pain medication.  In addition, the pharmacist who administered the vaccine refused to give me a receipt, and never recorded the vaccine, as he refused to give me a receipt. I went back there yesterday on September 15, 2023 and there was no record of me ever getting the vaccine. My arm still hurts a bit.
This case was reported by a pharmacist via call center representative and described the occurrence of anaphylaxis in a child female patient who received DTPa. On an unknown date, the patient received dtpa vaccine .5 ml. On an unknown date, an unknown time after receiving dtpa vaccine, the patient experienced anaphylaxis (serious criteria GSK medically significant). On an unknown date, the outcome of the anaphylaxis was unknown. It was unknown if the reporter considered the anaphylaxis to be related to dtpa vaccine. Additional details were provided as follows: The pharmacist called to inquire about data regarding a dilution for a de-sensitizing challenge for BOOSTRIX or Tetanus-allergic patients. The reporter knew very little information but that a patient several years ago had anaphylactic reaction to a D-tap vaccine (brand unknown). No other details were provided. This adverse event might have been reported previously but the reporter caller was unsure.
Vaccine exp. 10/7/2022 -(use by date) 8 weeks following - defrost VS Exp. date 10/31/2024
Patient presented to pharmacy complaining of welts that look like burns on back of shoulder, deltoid and chest on side where second Pfizer Covid dose was given almost one month prior. Patient states he did see a physician but was unclear (unable to explain or evasive) about treatment he received. He stated that the welts are not itchy, swollen or hot.
missed the second dose/ at appropriate time, first dose was administered on 17Sept2019 /second dose has not been administered; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 17th September 2019 with batch number 3FJ59 and expiry date 27th November 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follows: The age at vaccination was not applicable for this report. The patient missed the second dose of Shingrix at appropriate time and did not receive it till the time of reporting which led to incomplete course of vaccination. VAERS details were reported for 1st dose of Shingrix. The reporter consented to follow up via email. This case has been linked with US2021122643 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021122643:same reporter
Right arm numbness and tingling for several hours. Persisted in hand for 2-3 days.
nausea, vomiting, fatigue, HA, dizziness, Bel's Palsy
pt recv vax devel malaise, dec appetite, diarrhea, nausea on was seen by MD; dx w/mononucleosis; 18SEP94 seen in ER;  with lt upper quad abd pain; cont to have abd spasms & pain & has been unable to attend school 94-95yr dx fibromyalgia
Rash at injection site immediately on Friday , onset of flu like symptoms the night of injection body aches feeling hot and cold fatigue. Next day same followed by itchy throat and at night hives on my face chest tightness. I called the out of hours number of my medical practice and the doctor on call started me on Benadryl which I took that night and the next day ending Sunday.
Tinnitus.  Fairly constant from April 12th thru today (May 10th).  Right ear.  Fullness April 12th thru doctor visit later that week.
No additional adverse event; patient received improperly stored vaccine; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, and previous drug allergies or reactions were not reported.      On 20-FEB-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) injection (strength, dosage regimen, route of administration, and anatomical location were not reported; and lot number S000132 has been verified to be valid, expiration date reported and validated as 02-JAN-2021) as prophylaxis (product storage error). The sterile diluent (MERCK STERILE DILUENT) used to reconstitute the vaccine was properly stored. No additional adverse event.  The temperature excursion was reported as: temperature total time in the range 6 degrees Fahrenheit to 14 degrees Fahrenheit (-14 degrees Celsius to -10 degrees Celsius) 6.7 degrees Fahrenheit. The time frame was 5 minutes. No previous temperature excursions reported. A data logger was used.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2002USA010011:
After the first shot, her headache went away after 2 days; After the first shot, her headache went away after 2 days; dull pain; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 2 via an unspecified route of administration on an unspecified date as 2ND DOSE, SINGLE for covid-19 immunization. The patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as first dose, single for covid-19 immunization. The patient past medical history and concomitant medication was not reported. the patient reported that she received the second dose of the COVID vaccine 6 days ago. The first day after the second dose, she had no reaction, however, on the second day, she had a headache and still has a headache today that continues to get worse on an Unspecified date. She was not taking Ibuprofen every 4 hours and only took 2 tablets about 3 or 4 hours ago. She had dull pain that doesn't go away. The outcome of event was not recovered.  Information about lot/batch number has been requested.   Follow-up attempts are completed. No further information is expected. .; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021122285 similar report from same reporter
First dose of Moderna covid19 vaccine was taken on Feb-2021, second dose was taken on the May-2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of Moderna covid19 vaccine was taken on Feb-2021, second dose was taken on the May-2021) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient never had COVID positive test or diagnosis. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Drug allergy (Morphine allergy).   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of Moderna covid19 vaccine was taken on Feb-2021, second dose was taken on the May-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of Moderna covid19 vaccine was taken on Feb-2021, second dose was taken on the May-2021) outcome was unknown.            No relevant concomitant medications were reported. No other medical history relating to mentioned AE and both acute and chronic illnesses at the time of vaccination. The AE did not cause the patient to seek medical care (office visit, urgent care, ER, hospitalized). Patient did not experienced a similar event in the past. Treatment information was not provided by the reporter.   This case was linked to MOD-2022-613380 (Patient Link).
Vaccine stored in freezer too long resulting in a temperature excursion. Patient reported aches, shakes and chills (1-2 days).
01/09/23 presents to ED for "SOB". PMHx of "alcohol use disorder, ureteral stone, blind right eye"
Nausea + fatigue  (onset almost immediately) - still occurring at 48 hours out, which is time of submission. Shaking chills starting 6 hours after vaccine, continuing to about 36 hours after vaccine.  Fever of 101.5 starting about 10-11 hours after vaccine, lasting until about 30 hours after vaccine, then elevated but not as high (100) for another 12 hours.  Muscle aches and joint pain starting about 6 hours after vaccine and continuing still at 48 hours out (time of submission).  Took Tylenol regularly starting at 12 hours after vaccine until 36 hours after vaccine.
Discharge Provider: MD Primary Care Provider:MD Admission Date: 1/4/2023 Discharge Date: 1/7/23 COVID positive date: 01/04/2023  PRESENTING PROBLEM: Lung nodule  Hypoxia  Acute hypoxemic respiratory failure  Nausea and vomiting, unspecified vomiting type Respiratory tract infection due to COVID-19 virus    HOSPITAL COURSE: 65-year-old female with possible history of combined systolic and diastolic CHF with EF 10% status post ICD, AFib on Eliquis, hypertension, CKD 3, dyslipidemia.  Patient admitted with COVID and acute hypoxic respiratory failure after presenting with shortness of breath, cough, congestion, abdominal pain, nausea and chills.  She tested positive for COVID and was given a dose of Decadron.  She was initially hypoxic with ambulation and required 3 L of supplemental oxygen but was weaned back to room air prior to discharge.  CT abdomen and pelvis was without acute abnormality.  CTA chest was without evidence of PE but noted small right pleural effusion, mildly enlarged mediastinal lymph nodes which have been stable and consolidation in the left upper lobe with spiculated nodule in the right upper lobe.  Patient will need repeat CT within 3 months to re-evaluate.  She was felt to have a component of fluid overload at the time of admission and was placed on IV Lasix.  Cardiology was consulted but felt patient euvolemic and patient was transitioned back to home diuretics.  She had some soft blood pressures and hydralazine was held at discharge.  Aldactone was also decreased to 25 mg daily given poor orally intake in the setting of COVID.  She was instructed to monitor her blood pressure both morning and evening and keep a log to follow-up with cardiology.  She was instructed to call Cardiology if blood pressure became elevated or she had any evidence of volume overload, weight gain, worsening edema.  She was set up with the transition to home program.   Of note patient had productive cough so a sputum culture was sent and is pending at time of discharge.  Symptoms improved without antibiotic treatment.  She did culture to be followed up by transition to home program.
1/1 I started having metallic taste in my mouth. 1/2 I noticed the left side of my face was drooping. 1/3 It was worse so I spoke with a a co worker who is a paramedic who told me to go to the ER. I went to ER  and they diagnosed me with Bells Palsy.
Body aches, chills, and fever (101.3 at highest) starting approximately 8 hours after injection. Headache and minor nausea overnight. General fatigue and headache the next day. Felt back to normal on second day following shot.
Severe pain when taking deep breaths (left side).  Worse when lying down pain is nearly continuous.  Better when standing or sitting up but still severe with deep breaths.
developed chicken pox-like lesions around her varicella site  nine days after receiving vaccine. had received antibiotics 500 mg IM left thigh on 01/11/02
Injection site left arm - large red raised lump itchy (DTaP) warm compress, Motrin, Benadryl given.
Approximately 24 hours post vaccination,  chills, severe headache, general muscle aches,  malaise.
Mother stated that her son started to have vomiting about 15 min after immunizations were given.  Left arm had redness and swelling at injection site about 24 hours post immunizations.  Swelling and redness increased.  Site became warm to touch and painful.
- Faster heart rate (within 15 minutes of the injection); no treatment or observation sought (didn't think it was related until later reading it online) - Slight tingling in head and slight numbness is tongue and nose (approximately an hour after the injection); no treatment sought - read about similar instances online and since it was slight, I waited it out and they went away completely a few hours later.  The above events occurred within the first two after the injection
Information has been received from a healthcare worker concerning a 4 year old female with no pertinent medical history and no drug allergies, who was vaccinated with a second dose of MMR II (0.5ml, lot # 664606/0617Y) on 31-MAR-2010. Suspected therapy included a dose of VARIVAX. Concomitant therapy included DTaP, hepatitis A virus vaccine (unspecified) and poliovirus vaccine. On 31-MAR-2010 the patient developed cellulitis. The patient was taken to emergency room and given antibiotics and recovered that day. There were no labs or diagnostic tests performed. Follow up information has been received from a healthcare worker concerning a 4 year old female with no pre-existing drug allergies, who was vaccinated with a second dose of MMR II (lot # 664606/0617Y) on 31-MAR-2010 at 3:30 p.m. in the left deltoid. Suspect therapy included a second dose of VARIVAX (lot # 664614/0970Y) on 31-MAR-2010 at 3:30 p.m. in the right deltoid. Other concomitant therapies included a fifth dose of KINRIX (SKB, lot # ac20bi36aa) on 31-MAR-2010 at 3:30 p.m. in the left deltoid, and a dose of HAVRIX (SKB, lot # ahavb311ba). On 31-MAR-2010 at 3:30 p.m. the patient's left arm was red and swollen. The patient went to emergency room on 02-APR-2010 with cellulitis. The patient was given antibiotics and recovered on 05-APR-2010. No further information is available.
Information has been received from a nurse concerning a 12 month old healthy patient who on 17-JUL-2008 was vaccinated with a first dose of VARIVAX (Oka/Merck) (lot # 659457/1913U). Concomitant vaccination included a first dose of MMR and a first dose of Hep A (manufacturer unknown). On 23-JUL-2008 the patient had diarrhea and ear pain. On 28-JUL-2008 the patient was diagnosed with full chicken pox characterized by less than 50 lesions. On 28-JUL-2008 the patient had a temperature of 102 degrees F, scattered vesicular rash on body with pruritus. On 31-JUL-2008 the patient experienced vesicular rash on tongue and body. The patient's rash cleared on 07-AUG-2008. The patient was considered fully recovered on 07-AUG-2008. The patient's temperature was 99.4 degrees F. Patient's relevant diagnostics included a physical examination. On 07-AUG-2008, the patient was vaccinated with a second dose of VARIVAX (Oka/Merck) (lot # 65778/1861U). Additional information is not expected.
Pt states she had a mild sore throat for two weeks with lightheadedness. This progressed to laryngitis with body aches for a week and then she started to feel better slowly. No treatment rec'd.
Per patient severe internal itching all over including eyes. No visible rash/hives/whelps. 2:02 administered 50 mg IM Benadryl , blood pressure 148/98, 78 pulse, 22 respirations, lungs clear. 2:24 no relief from 50mg Benadryl IM, blood pressure 160/94, 88 pulse, 20 respirations, lungs left crackles. No angioedema or difficulty breathing . Instructed patient and her husband to go to free ER for further evaluation and to also follow up with primary care physician.
Systemic: Fainting / Unresponsive-Mild, Systemic: Visual Changes/Disturbances-Mild
pt recv vax 19APR96 & 30APR96 pt exp chicken pox less than 20 lesions;pt had a hx of exposure to chicken pox a/the vax;
Vaccine stored outside of manufacturer guidelines, product stability is unknown. Potential expired product used for immunization.  pt did not experience any adverse reactions to the vaccine after administration
PAIN in upper arm, neck, shoulder, progressively worsening on the left side at the site of vaccination
Beginning the night of the vaccination before bedtime, the patient described soreness of her left arm. This progressed to bad pain in the shoulder, fatigue, headache, much redness and swelling towards the elbow from the injection site and pain to the touch up and down the arm. Patient stated that it was starting to resolve 10/30 but still red and painful. She did want to visit a physician at this time. I will follow up with her 11/3/2016.
This case was reported by a pharmacist via call center representative and described the occurrence of adverse event in a patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The healthcare professional reported that the patient had a bad reaction after receiving the SHINGRIX. The healthcare professional had no details about what the reaction was. The reporter had no patient or vaccine information.
Information has been received from a nurse via a company representative referring to an 11 year old female patient. The patient was 15 years old at the time of the report. Concurrent conditions, medical history of the patient were not reported. On an unspecified date in 2011, when the patient was 11 year old, she was vaccinated with the first dose of GARDASIL injection (lot#, dose, route unspecified) and patient developed headaches "2-3 hours after" receiving the vaccine. Also when she was 11 years old, on an unspecified date of 2011, the patient received the second dose of GARDASIK injection (lot#, dose, route unspecified), and developed "a bunch of headaches" after receiving the vaccine. The patient did not receive a 3rd dose of GARDASIL. The outcome of headache was recovered at the time of the report (exact date was unspecified). No product quality complaint (PQC) involved. The relatedness between the event and therapy with GARDASIL was not reported. Additional information is not expected as we are not permitted to contact the physician.
Day after vaccine muscles were extremely sore. Three weeks later had ultrasound that showed fetal death at time and date of vaccine administered. 11/23/2009 received Immunization record received DOS 09/21/2009 - 10/19/2009. Patient received influenza (seasonal) vaccinaton on 09/21/2009 and influenza (H1N1) on 10/19/2009. 12/07/2009 received in-patient hospital records (H&P, operative report and labs) DOS 11/14/2009 -11/16/2009. Dx: Missed abortion/miscarriage Patient presented with vaginal bleeding, abdominal pain, intermittent headache, nausea and anxiety. The patient had experienced intermittent abdominal cramping throughout pregnancy, but on morning of admission, the abdominal cramping was worse and the patient experienced brownish vaginal discharge which progressed to red spotting. No fetal heartones were heard and a misoprostol induction was performed with fetal delivery (ultrasound est. 13 wks, 3 days) and then the patient underwent a suction D&C. due to retained placenta. The patient was treated with Ancef.   12/08/2009 received out-patient clinic and duplicate hospital records 09/21/2009 -12/07/2009.   Patient complaint hyper emesis, asthma symptoms. Clinic notes reflect GA 9weeks/4 days on 09/21/2009 and GA 13 weeks/4 days on 10/19/2009.
Patient received shingles vaccine on 2/9/09 at that time she did not note on VAR that she was immuno compromised.  On 3/2/09 the home healthcare nurse called to reportan outbreak of shingles due to the vaccine along with ultra sound.
fever, very cold, uncontrollable shanking, weakness, muscle pain and soreness, very low body temp. (94.5) than high (100.0). conditions are still with me today
started feeling dizzy;passed out on table;eyes opened wide, pupils dilated bilat apnea & stiffness, for approx 30sec w/no response;then regained consciousness, sat up fast;stated I was asleep for a few seconds;
Vaccinee (Case #5) rec'd a 1st dose of Engerix-B (rt Deltoid) on 23JAN90 p/testing showed had failed to respond to a pervious series of 3 "RECOMBIVAX" vax; Testing for titers on 5MAR90 indicated did not seroconvert;